D. E. Shaw & Co., Inc. Anika Therapeutics, Inc. Transaction History

D. E. Shaw & Co., Inc.

$98.6 Billion
Q2 2024

A detailed history of D. E. Shaw & Co., Inc. transactions in Anika Therapeutics, Inc. stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 152,923 shares of ANIK stock, worth $3.71 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

152,923

Previous 153,489 0.37%

Holding current value

$3.71 Million

Previous $3.9 Million 0.64%

% of portfolio

0.0%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$24.57 - $28.47 $13,906 - $16,114	-566 Reduced 0.37%	152,923 $3.87 Million
Q1 2024 May 15, 2024	SELL	$21.95 - $26.42 $345,822 - $416,247	-15,755 Reduced 9.31%	153,489 $3.9 Million
Q4 2023 Feb 14, 2024	SELL	$18.47 - $23.3 $421,503 - $531,729	-22,821 Reduced 11.88%	169,244 $3.84 Million
Q3 2023 Nov 14, 2023	BUY	$16.98 - $26.1 $821,628 - $1.26 Million	48,388 Added 33.68%	192,065 $3.58 Million
Q2 2023 Aug 14, 2023	BUY	$25.16 - $28.86 $136,115 - $156,132	5,410 Added 3.91%	143,677 $3.73 Million
Q1 2023 May 15, 2023	SELL	$25.91 - $32.1 $190,671 - $236,223	-7,359 Reduced 5.05%	138,267 $3.97 Million
Q4 2022 Feb 14, 2023	SELL	$23.85 - $31.91 $152,687 - $204,287	-6,402 Reduced 4.21%	145,626 $4.31 Million
Q3 2022 Nov 14, 2022	SELL	$21.74 - $24.68 $885,513 - $1.01 Million	-40,732 Reduced 21.13%	152,028 $3.62 Million
Q2 2022 Aug 15, 2022	BUY	$20.4 - $25.53 $456,368 - $571,131	22,371 Added 13.13%	192,760 $4.3 Million
Q1 2022 May 16, 2022	BUY	$24.7 - $36.54 $215,235 - $318,409	8,714 Added 5.39%	170,389 $4.28 Million
Q4 2021 Feb 14, 2022	SELL	$35.83 - $45.03 $580,696 - $729,801	-16,207 Reduced 9.11%	161,675 $5.79 Million
Q3 2021 Nov 15, 2021	SELL	$38.75 - $44.47 $578,692 - $664,114	-14,934 Reduced 7.75%	177,882 $7.57 Million
Q2 2021 Aug 16, 2021	BUY	$39.42 - $48.08 $17,463 - $21,299	443 Added 0.23%	192,816 $8.35 Million
Q1 2021 May 17, 2021	BUY	$32.49 - $45.96 $1.15 Million - $1.63 Million	35,478 Added 22.61%	192,373 $7.85 Million
Q4 2020 Feb 16, 2021	SELL	$32.59 - $45.26 $343,303 - $476,768	-10,534 Reduced 6.29%	156,895 $7.1 Million
Q3 2020 Nov 16, 2020	SELL	$32.56 - $38.57 $322,897 - $382,498	-9,917 Reduced 5.59%	167,429 $5.93 Million
Q2 2020 Aug 14, 2020	SELL	$27.83 - $37.73 $1.67 Million - $2.26 Million	-59,909 Reduced 25.25%	177,346 $6.69 Million
Q1 2020 May 15, 2020	SELL	$22.38 - $54.06 $1.86 Million - $4.49 Million	-83,127 Reduced 25.95%	237,255 $6.86 Million
Q4 2019 Feb 14, 2020	SELL	$51.85 - $73.36 $4.56 Million - $6.45 Million	-87,912 Reduced 21.53%	320,382 $16.6 Million
Q3 2019 Nov 14, 2019	SELL	$40.05 - $57.47 $190,517 - $273,384	-4,757 Reduced 1.15%	408,294 $22.4 Million
Q2 2019 Aug 14, 2019	BUY	$30.3 - $41.14 $3.07 Million - $4.17 Million	101,443 Added 32.55%	413,051 $16.8 Million
Q1 2019 May 15, 2019	BUY	$29.37 - $40.49 $4.41 Million - $6.08 Million	150,115 Added 92.95%	311,608 $9.42 Million
Q4 2018 Feb 14, 2019	SELL	$30.16 - $43.0 $18,156 - $25,886	-602 Reduced 0.37%	161,493 $5.43 Million
Q3 2018 Nov 14, 2018	BUY	$32.83 - $42.51 $2.33 Million - $3.02 Million	70,933 Added 77.81%	162,095 $6.84 Million
Q2 2018 Aug 14, 2018	SELL	$28.77 - $48.27 $486,817 - $816,776	-16,921 Reduced 15.66%	91,162 $2.92 Million
Q1 2018 May 15, 2018	SELL	$49.22 - $68.43 $940,298 - $1.31 Million	-19,104 Reduced 15.02%	108,083 $5.37 Million
Q4 2017 Feb 14, 2018	SELL	$52.14 - $59.94 $122,372 - $140,679	-2,347 Reduced 1.81%	127,187 $6.86 Million
Q3 2017 Nov 14, 2017	BUY	$51.16 - $58.21 $6.63 Million - $7.54 Million	129,534	129,534 $7.51 Million

Others Institutions Holding ANIK

# of Institutions

116

Shares Held

11.8M

Call Options Held

2.7K

Put Options Held

View Full List

About Anika Therapeutics, Inc.

Ticker ANIK
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 14,599,900
Market Cap $354M
Description
Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactur...

More about ANIK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account